FAQ updated for the CTIS training programme All news

May 15, 2026

FAQ updated for the CTIS training programme

The European Medicines Agency (EMA) has published an updated FAQ for the Clinical Trials Information…

Saad

Love0

👩‍⚕️ International Nurses Day All news

May 12, 2026

👩‍⚕️ International Nurses Day

Saad

Love0

CMDh publishes Guidance on the Informal Work-Sharing procedure for follow-up for PSUSA for NAPs All news

May 7, 2026

CMDh publishes Guidance on the Informal Work-Sharing procedure for follow-up for PSUSA for NAPs

Occasionally, it may not be possible to finalise an issue (e.g. a signal or a…

Saad

Love0

What if how you feel after taking a medication really mattered? All news

May 5, 2026

What if how you feel after taking a medication really mattered?

After taking a medication, you may notice something unusual: extreme tiredness, headaches, rashes, nausea… 👉…

Saad

Love0

Product Management Service (PMS) – Frequently Asked Questions (FAQs) All news

April 30, 2026

Product Management Service (PMS) – Frequently Asked Questions (FAQs)

The European Medicines Agency (EMA) has published a list of frequently asked questions (FAQs) collected…

Saad

Love0

Behind the Scenes of Pharmacovigilance : How PHARMYA ensures your safety All news

April 29, 2026

Behind the Scenes of Pharmacovigilance : How PHARMYA ensures your safety

Saad

Love0

💊 Every report matters. Every signal counts All news

April 23, 2026

💊 Every report matters. Every signal counts

Behind every medicine, there’s continuous monitoring to ensure safety for all. From rare side effects…

Saad

Love0

EMA publishes detailed guidance on electronic submission of authorized medicines All news

April 21, 2026

EMA publishes detailed guidance on electronic submission of authorized medicines

The European Medicines Agency (EMA) has published detailed XEVPRM user guidance on the electronic submission…

Saad 0

Love0

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 April 2026 All news

April 17, 2026

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 April 2026

The meeting highlights were published. PRAC agrees on communication to inform healthcare professionals that cases…

Saad 0

Love0

Behind each safe medication, there is a PV expert who analyses, prevents and protects All news

April 16, 2026

Behind each safe medication, there is a PV expert who analyses, prevents and protects

🔍 Discover the crucial role played by our experts at Pharmya, 🛡️ And how they…

Saad

Love0

EMA’s Data Protection Notice for the exchange of information during the Critical Medicines Vulnerability Assessment exercise All news

April 9, 2026

EMA’s Data Protection Notice for the exchange of information during the Critical Medicines Vulnerability Assessment exercise

The European Medicines Agency (EMA) has published a Data Protection Notice explaining the details of…

Saad

Love0

Social Media and Pharmacovigilance 📱💊 All news

March 31, 2026

Social Media and Pharmacovigilance 📱💊

In the digital age, social media has become an essential tool for healthcare professionals and…

Saad

Love0

World Tuberculosis Day : a major public health and pharmacovigilance challenge All news

March 24, 2026

World Tuberculosis Day : a major public health and pharmacovigilance challenge

🌍 World Tuberculosis Day : a major public health and pharmacovigilance challenge   🦠 Tuberculosis…

Saad

Love0

NDSG Workplan 2026-2028: Data and AI in medicines regulation All news

March 23, 2026

NDSG Workplan 2026-2028: Data and AI in medicines regulation

Following the first workplan adopted in March 2025, the joint HMA/ EMA Network Data Steering…

Saad

Love0

Discover Pharmya – Your Partner in Pharmacovigilance All news

March 18, 2026

Discover Pharmya – Your Partner in Pharmacovigilance

Ensuring drug safety and regulatory compliance is essential in today’s healthcare landscape. At Pharmya, we…

Saad

Love0

EU implementation strategy of ICH E2D (R1) Guideline – post approval safety data: definitions and standards for management and reporting of individual case safety report All news

March 11, 2026

EU implementation strategy of ICH E2D (R1) Guideline – post approval safety data: definitions and standards for management and reporting of individual case safety report

The European Medicines Agency (EMA) has published the ICH E2D (R1) guidelines, which comes officially…

Saad

Love0

Understanding EudraVigilance All news

March 5, 2026

Understanding EudraVigilance

💊 What is EudraVigilance?   EudraVigilance is the European pharmacovigilance database 📊. It collects and…

Saad

Love0

A few key numbers All news

March 3, 2026

A few key numbers

Growth. Quality. Expertise. 🚀✨ Here’s a snapshot of our journey:

Saad

Love0

Rare Disease Day All news

February 27, 2026

Rare Disease Day

Rare Disease Day – 28 February 2026 🌍 Every year on 28 February, Rare Disease…

Saad

Love0

Final training module issued for ICH guideline E2B (R3) All news

February 24, 2026

Final training module issued for ICH guideline E2B (R3)

ICH has published Implementation Guide for Electronic Transmission of Individual Case Safety Reports (ICSRs), Module…

Saad

Love0